日本語English简体中文 繁體中文

300199 Hybio Pharmaceutical Co., Ltd.翰宇药业Shenzhen Stock Exchange

11 posts

Hybio Pharmaceutical Co., Ltd. (300199) at a glance

Code
300199
Company
Hybio Pharmaceutical Co., Ltd.
Local name
翰宇药业
Market
Shenzhen Stock Exchange
Share price
CN¥23.55 -0.59 (-2.44%) Nov 9 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Hybio Pharmaceutical Co., Ltd. (300199) Stock Price History

Hybio Pharmaceutical Co., Ltd. closed at CN¥23.55 on Nov 9, 2026, −0.7% over 1 month, +15.0% over 1 year.

2026-10-09 新薬・製品の承認 关于HY3003注射液获得美国FDA临床试验申请受理的公告2026-10-13 業績予想 2026年前三季度业绩预告 / 第三者割当増資 关于2025年度向特定对象发行A股股票方案到期的公告2026-10-27 新薬・製品の承認 关于全资子公司投资建设多肽药物产线绿色化智能化扩建项目的公告 / 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十八次会议决议公告 / 株主総会の招集 关于召开2026年第四次临时股东会的通知 / 資産の減損 关于2026年前三季度计提资产减值准备及信用减值准备的公告 / 会計監査人の選任 关于拟续聘2026年度会计师事务所的公告2026-11-05 新薬・製品の承認 关于HY3003注射液获得美国FDA临床试验许可的公告2026-11-06 新薬・製品の承認 关于HY3003片获得药物临床试验申请受理通知书的公告CN¥26.71CN¥21.21Oct 9Nov 9
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥26.71Oct 21
1-Month LowCN¥21.21Nov 3
1-Week Change+6.6%vs Nov 2
1-Month Change−0.7%vs Oct 9

If you had invested CN¥10,000 1 month ago, it would be worth CN¥9,933 today (−0.7%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.3%, while this stock moved −0.7%.

Last 10 Trading Days

DateCloseChange% Change
Nov 9 (Mon)CN¥23.55−0.59−2.44%
Nov 6 (Fri)CN¥24.14−0.73−2.94%
Nov 5 (Thu)CN¥24.87+2.16+9.51%
Nov 4 (Wed)CN¥22.71+1.50+7.07%
Nov 3 (Tue)CN¥21.21−0.88−3.98%
Nov 2 (Mon)CN¥22.09+0.23+1.05%
Oct 30 (Fri)CN¥21.86−0.45−2.02%
Oct 29 (Thu)CN¥22.31−0.85−3.67%
Oct 28 (Wed)CN¥23.16−0.04−0.17%
Oct 27 (Tue)CN¥23.20−1.24−5.07%
2026-10-09 新薬・製品の承認 关于HY3003注射液获得美国FDA临床试验申请受理的公告2026-10-13 業績予想 2026年前三季度业绩预告 / 第三者割当増資 关于2025年度向特定对象发行A股股票方案到期的公告2026-10-27 新薬・製品の承認 关于全资子公司投资建设多肽药物产线绿色化智能化扩建项目的公告 / 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十八次会议决议公告 / 株主総会の招集 关于召开2026年第四次临时股东会的通知 / 資産の減損 关于2026年前三季度计提资产减值准备及信用减值准备的公告 / 会計監査人の選任 关于拟续聘2026年度会计师事务所的公告2026-11-05 新薬・製品の承認 关于HY3003注射液获得美国FDA临床试验许可的公告2026-11-06 新薬・製品の承認 关于HY3003片获得药物临床试验申请受理通知书的公告CN¥26.71CN¥21.21Aug 10Nov 9
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥26.71Oct 21
3-Month LowCN¥21.21Nov 3
1-Month Change−0.7%vs Oct 9
3-Month Change−3.4%vs Aug 7

If you had invested CN¥10,000 3 months ago, it would be worth CN¥9,330 today (−6.7%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −8.0%, while this stock moved −6.7%.

Last 10 Trading Days

DateCloseChange% Change
Nov 9 (Mon)CN¥23.55−0.59−2.44%
Nov 6 (Fri)CN¥24.14−0.73−2.94%
Nov 5 (Thu)CN¥24.87+2.16+9.51%
Nov 4 (Wed)CN¥22.71+1.50+7.07%
Nov 3 (Tue)CN¥21.21−0.88−3.98%
Nov 2 (Mon)CN¥22.09+0.23+1.05%
Oct 30 (Fri)CN¥21.86−0.45−2.02%
Oct 29 (Thu)CN¥22.31−0.85−3.67%
Oct 28 (Wed)CN¥23.16−0.04−0.17%
Oct 27 (Tue)CN¥23.20−1.24−5.07%
2026-10-09 新薬・製品の承認 关于HY3003注射液获得美国FDA临床试验申请受理的公告2026-10-13 業績予想 2026年前三季度业绩预告 / 第三者割当増資 关于2025年度向特定对象发行A股股票方案到期的公告2026-10-27 新薬・製品の承認 关于全资子公司投资建设多肽药物产线绿色化智能化扩建项目的公告 / 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十八次会议决议公告 / 株主総会の招集 关于召开2026年第四次临时股东会的通知 / 資産の減損 关于2026年前三季度计提资产减值准备及信用减值准备的公告 / 会計監査人の選任 关于拟续聘2026年度会计师事务所的公告2026-11-05 新薬・製品の承認 关于HY3003注射液获得美国FDA临床试验许可的公告2026-11-06 新薬・製品の承認 关于HY3003片获得药物临床试验申请受理通知书的公告CN¥26.71CN¥19.77May 11Nov 9
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥26.71Oct 21
6-Month LowCN¥19.77Jun 26
3-Month Change−3.4%vs Aug 7
6-Month Change+15.2%vs May 8

If you had invested CN¥10,000 6 months ago, it would be worth CN¥11,482 today (+14.8%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −13.6%, while this stock moved +14.8%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥23.55+7.7%
Oct 2026CN¥21.86−8.6%
Sep 2026CN¥23.92+4.2%
Aug 2026CN¥22.96+8.8%
Jul 2026CN¥21.10−4.4%
Jun 2026CN¥22.08−4.5%
May 2026CN¥23.11+11.4%
2026-10-09 新薬・製品の承認 关于HY3003注射液获得美国FDA临床试验申请受理的公告2026-10-13 業績予想 2026年前三季度业绩预告 / 第三者割当増資 关于2025年度向特定对象发行A股股票方案到期的公告2026-10-27 新薬・製品の承認 关于全资子公司投资建设多肽药物产线绿色化智能化扩建项目的公告 / 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十八次会议决议公告 / 株主総会の招集 关于召开2026年第四次临时股东会的通知 / 資産の減損 关于2026年前三季度计提资产减值准备及信用减值准备的公告 / 会計監査人の選任 关于拟续聘2026年度会计师事务所的公告2026-11-05 新薬・製品の承認 关于HY3003注射液获得美国FDA临床试验许可的公告2026-11-06 新薬・製品の承認 关于HY3003片获得药物临床试验申请受理通知书的公告CN¥26.71CN¥16.36Nov 10Nov 9
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥26.71Oct 21
52-Week LowCN¥16.36Mar 4
Year to Date+31.6%vs Dec 31
From 52-Week High−11.8%Oct 21

If you had invested CN¥10,000 1 year ago, it would be worth CN¥11,578 today (+15.8%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −9.2%, while this stock moved +15.8%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥23.55+7.7%
Oct 2026CN¥21.86−8.6%
Sep 2026CN¥23.92+4.2%
Aug 2026CN¥22.96+8.8%
Jul 2026CN¥21.10−4.4%
Jun 2026CN¥22.08−4.5%
May 2026CN¥23.11+11.4%
Apr 2026CN¥20.74+9.9%
Mar 2026CN¥18.88+2.9%
Feb 2026CN¥18.34−3.0%
Jan 2026CN¥18.91+5.6%
Dec 2025CN¥17.90−2.6%
Nov 2025CN¥18.38−12.7%
CN¥28.32CN¥9.00Nov 13, 2023Nov 9, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥28.32Aug 18, 2025
3-Year LowCN¥9.00Jul 22, 2024
Annualized Return+15.8%
Max Drawdown−47.0%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥15,514 today (+55.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +19.5%, while this stock moved +55.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥23.55+31.6%
2025CN¥17.90―
CN¥28.32CN¥7.53Nov 15, 2021Nov 9, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥28.32Aug 18, 2025
5-Year LowCN¥7.53Dec 6, 2021
Annualized Return+23.0%
Max Drawdown−61.8%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥28,069 today (+180.7%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +2.5%, while this stock moved +180.7%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥23.55+31.6%
2025CN¥17.90―
CN¥34.89CN¥3.16May 1, 2011Nov 9, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥34.89May 2015
All-Time LowCN¥3.16Nov 2012
Total Change+471.7%vs May 2011
Annualized Return+11.9%

If you had invested CN¥10,000 in May 2011, it would be worth CN¥57,174 today (+471.7%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +33.0%, while this stock moved +471.7%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥23.55+31.6%
2025CN¥17.90+38.9%
2024CN¥12.89−5.1%
2023CN¥13.58−22.8%
2022CN¥17.58+39.4%
2021CN¥12.61+89.6%
2020CN¥6.65+14.7%
2019CN¥5.80−37.9%
2018CN¥9.34−42.6%
2017CN¥16.28−9.5%
2016CN¥17.98−27.0%
2015CN¥24.63+82.4%
2014CN¥13.50+27.4%
2013CN¥10.60+207.5%
2012CN¥3.45−27.0%
2011CN¥4.73―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from May 2011). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.11 Disclosure 2026/11/06 09:00
新薬・製品の承認
关于HY3003片获得药物临床试验申请受理通知书的公告
Delete
No.10 Disclosure 2026/11/05 09:00
新薬・製品の承認
关于HY3003注射液获得美国FDA临床试验许可的公告
Delete
No.9 Disclosure 2026/10/27 09:00
会計監査人の選任
关于拟续聘2026年度会计师事务所的公告
Delete
No.8 Disclosure 2026/10/27 09:00
資産の減損
关于2026年前三季度计提资产减值准备及信用减值准备的公告
Delete
No.7 Disclosure 2026/10/27 09:00
株主総会の招集
关于召开2026年第四次临时股东会的通知
Delete
No.6 Disclosure 2026/10/27 09:00
取締役会決議
第六届董事会第十八次会议决议公告
Delete
No.5 Disclosure 2026/10/27 09:00
四半期報告
2026年三季度报告
Delete
No.4 Disclosure 2026/10/27 09:00
新薬・製品の承認
关于全资子公司投资建设多肽药物产线绿色化智能化扩建项目的公告
Delete
No.3 Disclosure 2026/10/13 09:00
第三者割当増資
关于2025年度向特定对象发行A股股票方案到期的公告
Delete
No.2 Disclosure 2026/10/13 09:00
業績予想
2026年前三季度业绩预告
Delete
No.1 Disclosure 2026/10/09 09:00
新薬・製品の承認
关于HY3003注射液获得美国FDA临床试验申请受理的公告
Delete

Write on the Hybio Pharmaceutical Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English